EA200870525A1 - PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS - Google Patents

PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS

Info

Publication number
EA200870525A1
EA200870525A1 EA200870525A EA200870525A EA200870525A1 EA 200870525 A1 EA200870525 A1 EA 200870525A1 EA 200870525 A EA200870525 A EA 200870525A EA 200870525 A EA200870525 A EA 200870525A EA 200870525 A1 EA200870525 A1 EA 200870525A1
Authority
EA
Eurasian Patent Office
Prior art keywords
polymorphic forms
pharmaceutically acceptable
acceptable salts
new
salts
Prior art date
Application number
EA200870525A
Other languages
Russian (ru)
Inventor
Кресо Михальевич
Блаженко Байич
Гордан Динтер
Эрнест Мештрович
Ана Квокал
Original Assignee
Плива Хрватска Д.О.О.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива Хрватска Д.О.О. filed Critical Плива Хрватска Д.О.О.
Publication of EA200870525A1 publication Critical patent/EA200870525A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к новым ризедронатам и их новым полиморфным формам, конкретно к фармацевтически приемлемым солям ризедроновой кислоты, содержащим четыре атома щелочного металла, и их новым полиморфным формам, способу их получения, содержащим их фармацевтическим композициям, их терапевтическому применению, а также способам лечения с применением указанных солей.The present invention relates to new risedronate and their new polymorphic forms, specifically to pharmaceutically acceptable salts of risedronic acid containing four alkali metal atoms, and their new polymorphic forms, their method of preparation, their pharmaceutical compositions, their therapeutic use, and methods of treatment with the use of these salts.

EA200870525A 2006-05-12 2007-03-06 PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS EA200870525A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0609465.0A GB0609465D0 (en) 2006-05-12 2006-05-12 Pharmaceutically acceptable salts and polymorphic forms
PCT/GB2007/000792 WO2007132138A1 (en) 2006-05-12 2007-03-06 Pharmaceutically acceptable salts and polymorphic forms

Publications (1)

Publication Number Publication Date
EA200870525A1 true EA200870525A1 (en) 2009-04-28

Family

ID=36637404

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870525A EA200870525A1 (en) 2006-05-12 2007-03-06 PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS

Country Status (5)

Country Link
EP (1) EP2018392A1 (en)
CA (1) CA2649489A1 (en)
EA (1) EA200870525A1 (en)
GB (1) GB0609465D0 (en)
WO (1) WO2007132138A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007132478A2 (en) 2006-05-11 2007-11-22 Ind-Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293349B6 (en) * 2002-10-25 2004-04-14 Léčiva, A.S. Novel crystalline form of 3-pyridyl-1-hydroxyethylidene-1,1-bisphopshonoc acid sodium salt

Also Published As

Publication number Publication date
CA2649489A1 (en) 2007-11-22
EP2018392A1 (en) 2009-01-28
GB0609465D0 (en) 2006-06-21
WO2007132138A1 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
EA201001159A1 (en) Condensed Heterocyclic Derivatives and Their Application
EA201590371A1 (en) 1,4-DESIGNED PYRIDAZIN ANALOGUES AND METHODS OF TREATMENT RELATED TO SMN DEFICIENCY CONDITIONS
EA201390772A1 (en) NEW SALTS AND POLYMORPHIC FORMS OF AFATINIBA
ATE517882T1 (en) QUINOLINE DERIVATIVES
EA201692506A2 (en) ANTI-FLY VIRUS REPLICATION INHIBITORS
EA201200763A1 (en) SUBSTITUTED DERIVATIVES OF CARBAMOILMETYLAMINO ACID ACID AS NEW INHIBITORS NEP
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
EA200901133A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
EA201270492A1 (en) COMPOUNDS FOR THE TREATMENT OF DISLIPIDEMIC AND RELATED DISEASES
EA201290980A1 (en) DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBURONIC ACID
EA201101583A1 (en) PI3 KINASE OR MTOR INHIBITORS
EA201201161A1 (en) PYRROPYRIMIDINES AS CDK4 / 6 INHIBITORS
EA201592256A1 (en) DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES
EA201170508A1 (en) DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBURONIC ACID
EA201500430A1 (en) COMPOUNDS OF BONONATE AIR AND ITS PHARMACEUTICAL COMPOSITIONS
EA201101672A1 (en) SUBSTITUTED DERIVATIVES OF AMINOISAL ACID AS NEPRILISIN INHIBITORS
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
EA201290184A1 (en) BENZODIAZEPINUM INHIBITOR BROMODOMENE
EA200901138A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
UA111841C2 (en) BENZOTHIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATION
EA201201031A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201391263A1 (en) COMBINED THERAPIES OF HEMATOLOGICAL TUMORS
EA201390579A1 (en) HINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS PI3-KINASE INHIBITORS
EA201290416A1 (en) NEW SPYROPYPERIDINE CONNECTIONS
EA201300250A1 (en) OXADIAZOL INHIBITORS OF LEUKOTRIEN PRODUCTION